1 Min Read
Oct 11 (Reuters) - Immucell Corp
* Immucell Corp - U.S. FDA approval for co’s product Mast Out anticipated in 2019, allowing for two, six-month reviews of cmc technical section by FDA Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.